NEPHROCARE logo

Nephro Care India Limited Stock Price

NSEI:NEPHROCARE Community·₹938.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NEPHROCARE Share Price Performance

₹0
-137.30 (-100.00%)
₹0
-137.30 (-100.00%)
Price ₹0

NEPHROCARE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
1 Reward

Nephro Care India Limited Key Details

₹761.6m

Revenue

₹354.7m

Cost of Revenue

₹406.9m

Gross Profit

₹376.0m

Other Expenses

₹30.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.88
53.42%
4.06%
0%
View Full Analysis

About NEPHROCARE

Founded
2014
Employees
334
CEO
Pratim Sengupta
WebsiteView website
www.nephrocareindia.com

Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilitation programs. Its clinics provides renal transplant, urology, vascular surgery, carepath diagnostics, digital radiology, cardiology, OT facilities, women welfare services. In addition, the company offers pulmonary function test, EMG/NCV-testing, uroflowmetry, EEG, polysomnography, and retinal screening services. The company was incorporated in 2014 and is based in Kolkata, India.

Recent NEPHROCARE News & Updates

Recent updates

No updates